Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Upstart Holdings Shares Slide Despite Impressive Quarterly Performance

Dieter Jaworski by Dieter Jaworski
September 26, 2025
in Analysis, Earnings, Nasdaq, Tech & Software, Trading & Momentum
0
Upstart Holdings Stock
0
SHARES
132
VIEWS
Share on FacebookShare on Twitter

Upstart Holdings, the AI-driven lending platform, finds itself mired in a significant downturn. The stock concluded yesterday’s trading session at $56.93, marking a single-day decline of 6.07%. This drop contributes to a substantial weekly loss of twelve percent, underscoring a pronounced period of weakness for the company.

Sector-Wide Challenges and Technical Bearishness

The current bearish sentiment appears to extend beyond Upstart. The company’s direct competitor, Affirm, experienced an even steeper decline of 11.3% over the same week, suggesting the entire fintech lending sector is facing headwinds. From a charting perspective, the technical analysis confirms a negative outlook. A clear downtrend is in place, evidenced by the 20-day moving average falling below the 60-day average. Key resistance levels are now established at $73.47 and $79.31, while support lies at $54.59 and $48.75. A decisive break below these support thresholds could precipitate further losses. The stock is currently trading in the lower half of its 52-week range, which spans from $31.40 to $96.43.

Soaring Short Interest Points to Deep Skepticism

A report from Jefferies highlights a critical factor behind the selling pressure: a dramatic surge in short interest. Upstart recorded the most significant increase in short selling within the entire consumer finance sector. In August, the short interest ratio skyrocketed by 606 basis points, reaching 27.7% of the free float. This data signals profound investor skepticism regarding the company’s near-term prospects. While the broader fintech sector also saw a rise in short bets, the level of pessimism directed at Upstart is notably more intense.

Should investors sell immediately? Or is it worth buying Upstart Holdings?

Strong Q2 2025 Results Fail to Halt the Decline

The persistent decline is particularly striking given the robust quarterly results Upstart announced on August 5, 2025. The company delivered a report that surpassed analyst expectations across key metrics:

  • Revenue reached $257.29 million, representing a year-over-year increase of 101.6%.
  • Adjusted earnings per share came in at $0.36, beating the forecast of $0.27.
  • The company reported a GAAP net income of $5.6 million, a positive swing from a loss in the prior year.
  • Loan origination volume hit $2.8 billion, the highest level seen in three years.

Despite these strong fundamental achievements, the stock failed to find sustained upward momentum. This divergence raises a pivotal question for investors: is the current downtrend an overreaction, or are short sellers anticipating challenges that the recent earnings did not address?

Analyst consensus currently clusters around a “Hold” rating for Upstart shares, with price targets ranging from $65.60 to an average of $81.08. For now, a clear directional catalyst remains elusive.

Ad

Upstart Holdings Stock: Buy or Sell?! New Upstart Holdings Analysis from March 25 delivers the answer:

The latest Upstart Holdings figures speak for themselves: Urgent action needed for Upstart Holdings investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Upstart Holdings: Buy or sell? Read more here...

Tags: Upstart Holdings
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
SOXX ETF Stock
Commodities

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Next Post
Delta Air Lines Stock

Delta Air Lines Navigates Strategic Shift Amid Steady Dividend Payouts

Reviva Pharmaceuticals Holdings Stock

Reviva Pharmaceuticals Shares Plummet Following Equity Offering

ProShares Bitcoin Strategy ETF Stock

Bitcoin Futures ETF Weathers Market Volatility Despite Recent Pressure

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com